Predict your next investment

HEALTHCARE | Biotechnology
ensembletx.com

See what CB Insights has to offer

Founded Year

2002

Stage

Dead | Dead

Total Raised

$15M

About Ensemble Therapeutics

Ensemble Therapeutics is an early stage company focused on translating fundamental innovation in chemical discovery into products that address needs life science, materials, electronics, and chemical markets.

Ensemble Therapeutics Headquarter Location

99 Erie Street

Cambridge, Massachusetts, 02139,

United States

617-492-6977

Latest Ensemble Therapeutics News

Ensemble Therapeutics Corp Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 27092018 Prices from USD $250

Oct 28, 2018

08:13 EDT 28 Oct 2018 | BioPortfolio Reports Summary Ensemble Therapeutics Corp Ensemble, formerly Ensemble Discovery Corp is a developer of small molecule therapies for the treatment of cancer and other serious diseases. The company develops its products using its proprietary drug discovery platform. Its products under development are used for the treatment of various therapeutic areas including prostate , colorectal, pancreatic, cervical, gastric, ovarian, and lung cancers; parkinson's, hepatitis B and cardiovascular, among others. The company has partnership with various pharmaceutical companies to develop its small molecule therapies. Ensemble is headquartered in Cambridge, Massachusetts, the US. Ensemble Therapeutics Corp Pharmaceuticals Healthcare Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions MAs, partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, subsector and regions. GlobalData derived the data presented in this report from proprietary inhouse Pharma eTrack deals database, and primary and secondary research. Scope Financial Deals Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships. Deals by Year Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period. Deals by Type Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc. Deals by Region Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America. Deals by Subsector Chart and table showing information on the number of deals and value reported by the company, by subsector. Major Deals Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's major public companies key financial metrics and ratios. Business Description A brief description of the company's operations. Key Employees A list of the key executives of the company. Important Locations and Subsidiaries A list and contact details of key centers of operation and subsidiaries of the company. Key Competitors A list of the key competitors of the company. Key Recent Developments A brief on recent news about the company. Reasons to Buy Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period. Understand the company's business segments' expansion / divestiture strategy The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy. Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios. Equip yourself with detailed information about the company's operations to identify potential customers and suppliers. The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors. Stay uptodate on the major developments affecting the company Recent developments concerning the company presented in the profile help you track important events. Gain key insights into the company for academic or business research Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs. Note*: Some sections may be missing if data is unavailable for the company. Related Biotechnology, Pharmaceutical and Healthcare News

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Ensemble Therapeutics Patents

Ensemble Therapeutics has filed 6 patents.

patents chart

Application Date

Grant Date

Title

Related Topics

Status

11/7/2013

3/28/2017

Experimental cancer drugs, Programmed cell death, Protein kinase inhibitors, Fluoroarenes, Cancer treatments

Grant

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Application Date

11/7/2013

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Grant Date

3/28/2017

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Title

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Related Topics

Experimental cancer drugs, Programmed cell death, Protein kinase inhibitors, Fluoroarenes, Cancer treatments

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Grant

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.